MIRAVANT MEDICAL TECHNOLOGIES
SC 13G/A, 1998-02-12
PHARMACEUTICAL PREPARATIONS
Previous: HARBOUR INTERMODAL LTD /DE/, 10QSB/A, 1998-02-12
Next: MIRAVANT MEDICAL TECHNOLOGIES, SC 13G, 1998-02-12



<PAGE>   1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934

AMENDMENT NO:     2

Name of Issuer:   Miravant Medical Technologies, Inc. (formerly known as PDT,
Inc.)

Title of Class of Securities:       Common Stock

CUSIP Number:     69329P

Name, address and telephone number of person authorized to receive Notice and
Communications:

                           K. Leonard Judson, Esq.
                           May, Potenza, Judson & Baran, P.C.
                           201 North Central Avenue, Suite 2210
                           Phoenix, AZ  85073-0022
                           (602) 252-1110

Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

CUSIP No.:  69329P

1.       NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON

         Paul F. Glenn, Trustee, Paul F. Glenn Revocable Trust; SS# 206 24 0752

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)               [  ]
         (b)               [  ]

3.       SEC USE ONLY


                                   Page 1 of 4
<PAGE>   2
4.       CITIZENSHIP OR PLACE OF ORGANIZATION

         Paul F. Glenn is a United States citizen and the Paul F. Glenn
         Revocable Trust is formed under the laws of the State of Arizona

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5.       SOLE VOTING POWER
                  827,160

         6.       SHARE VOTING POWER
                  -0-

         7.       SOLE DISPOSITIVE POWER
                  827,160

         8.       SHARED DISPOSITIVE POWER
                  -0-

9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
         827,160

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

         [  ]

11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
         5.88%

12.      TYPE OF REPORTING PERSON*
         Paul F. Glenn - IN
         Paul F. Glenn Revocable Trust - 00

Item 1 (a)        Name of Issuer:
                  Miravant Medical Technologies, Inc. (formerly known as PDT,
                  Inc.)

Item 1 (b)        Address of Principal Business Office, or, if none, Resident
                  7408 Hollister Avenue, Santa Barbara, CA  93117

Item 2 (a)        Name of Person Filing:
                  Paul F. Glenn, as Trustee of the Paul F. Glenn Revocable
                  Trust, an Arizona revocable trust created by Declaration of
                  Trust, dated August 23, 1990, as amended through the date
                  hereof. Mr. Glenn is the sole trustee of the Paul F. Glenn
                  Revocable Trust and has the same business address ("Reporting
                  Person")

Item 2 (b)        Address of Principal Business Office or Residence:
                  P.O. Box 50310, Santa Barbara, CA  93150


                                   Page 2 of 4
<PAGE>   3
Item 2 (c)        Citizenship:
                  Reporting Person is a United States citizen

Item 2 (d)        Title of Class of Securities:
                  Common Stock

Item 2 (e)        CUSIP Number:
                  69329P

Item 3 (a)        If this statement is filed pursuant to Rule 13d-1(b), or
                  13d-2(b), check whether the person filing is a : 
                  This statement is not filed pursuant to the foregoing rules.

Item 4 (a)        Amount Beneficially Ownership
                  827,160

Item 4 (b)        Percent of class:
                  5.88% (827,160 (divided by) 14,064,288 issued and outstanding
                  as of  October 31, 1997)

Item 4 (c)        Number of shares as to which such person has:

                  (i)      sole power to vote or to direct the vote:  827,160

                  (ii)     shared power to vote or to direct the vote:  -0-

                  (iii)    sole power to dispose or to direct the disposition 
                           of: 827,160

                  (iv)     shared power to dispose or to direct the disposition 
                           of:  -0-

                  The Reporting Person has not acquired or disposed of any
                  securities of the Issuer during the reporting period. The
                  change of percentage ownership of the Reporting Person is as a
                  consequence of additional issuances of securities by the
                  Issuer.

Item 5            Ownership of Five Percent or Less of a Class

                  This statement is not being filed to report the fact that the
                  Reporting Person has ceased to be the beneficial owner of more
                  than five percent of the class of securities identified
                  herein.

Item 6            Ownership of More than Five Percent on Behalf of Another 
                  Person

                  Other than the Reporting Person, no other person has any right
                  to receive or the power to direct the receipt of dividends
                  from, or the proceed or sales of the securities identified in
                  this Schedule 13G.


                                   Page 3 of 4
<PAGE>   4
Item 7            Identification and Classification of the Subsidiary which
                  Acquired the Security Being Reported on by the Parent Holding
                  Company

                  This Schedule 13G is not being filed on behalf of a parent
                  holding company or a subsidiary.

Item 8            Identification and Classification of Members of the Group

                  This Schedule 13G is not being filed on behalf of any group.

Item 9            Notice of Dissolution of Group

                  No notice of dissolution of a group is reported in this
                  Schedule 13G.

Item 10           Certification

                  By signing below I certify that, to the best of my knowledge
                  and belief, the securities referred to above were acquired in
                  the ordinary course of business and were not acquired for the
                  purpose of and do not have the effect of changing or
                  influencing the control of the issuer of such securities and
                  were not acquired in connection with or as part of any
                  transaction having such purposes or effect.

SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

         Dated:   February 12, 1998

         /s/ K. Leonard Judson
         ------------------------------------------------------
         Paul F. Glenn, by K. Leonard Judson, Attorney-in
         Fact for Paul F. Glenn (Power of Attorney for execution
         by K. Leonard Judson, on behalf of Paul F. Glenn, has
         been previously filed with the United States Securities
         and Exchange Commission)


                                   Page 4 of 4



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission